Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $734.0600 (-1.7%) ($734.0600 - $734.0600) on Wed. Oct. 26, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.01% (three month average) | RSI | 51 | Latest Price | $734.0600(-1.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.7% a day on average for past five trading days. | Weekly Trend | REGN declines -0.2% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(50%) DIA(33%) SPLV(30%) IWD(29%) SDY(28%) | Factors Impacting REGN price | REGN will decline at least -1.505% in a week (0% probabilities). TBT(-13%) VCSH(-2%) UUP(-2%) URA(-2%) VIXM(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.505% (StdDev 3.01%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $727.5(0.9%) | 10 Day Moving Average | $729.29(0.65%) | 20 Day Moving Average | $727.59(0.89%) | To recent high | -2.5% | To recent low | 27.9% | Market Cap | $77.831b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |